West Palm Beach, FL (April 18, 2019) – Healthcare is a topical discussion issue and the Business Development Board of Palm Beach County focused on the growing life sciences industry during their quarterly Economic Development luncheon that took place at the Kravis Center in West Palm Beach, Florida.
A prominent group of 150 guests listened as three experts in healthcare finance and operations spoke about the emerging life sciences market in Florida and the Palm Beach County-based companies ready to serve their specialized business requirements.
Alan Wink, Director of Capital Markets at EisnerAmper, an accounting, advisory and tax services firm, outlined methods for pharmaceutical manufacturers to acquire investment capital. Wink also provided an overview of venture capital deal activity in Florida and economic trends that demonstrate growing awareness among the investing community for Florida-based healthcare businesses.
Life science companies with the necessary financial structure and management may decide to seek capital from public markets including the New York Stock Exchange or the NASDAQ, according to R. Doug Armstrong, co-owner of Dawson James Securities. Although predominantly recognized for generating large amounts of investment funds, public exchanges may be the answer for smaller capitalization levels in certain situations, according to Armstrong, who provided case studies of Florida companies that achieved funding goals utilizing this strategy.
WDSrx President Adam Runsdorf began his remarks by reviewing the origin of the company in Boca Raton, Florida. The pharmaceutical logistics services provider began operations in 2010 with two employees and one client in a single warehouse that occupied part of a larger building. Today, over 200 employees serve clients in seven pharmaceutical warehouse facilities located in Florida, Ohio, New Jersey and Texas.
Runsdorf also discussed how newly-commercialized pharmaceutical manufacturers and virtual manufacturers achieve efficiencies and increase productivity by outsourcing supply chain management to WDSrx or another reputable logistics services provider.
Seated at the WDSrx table were prominent life sciences professionals and community business leaders including BDB Board Member Gary Lesser, Esq., of Lesser, Lesser, Landy and Smith PLLC; Bart Bishop, Senior Vice-President at Fifth Third Bank; Guy Fronstin, Esq. of the Law Offices of Guy Fronstin, P.A.; Michael Feuerman, Esq., Senior Vice President of Berger Commercial Realty; Nancy Bryan, President and CEO of BioFlorida; Stacey Silver, BioFlorida Vice President of Marketing and Membership; Mark Eidemueller and Blake Miller of Wasena Capital Management, Inc.; and Neil Weiss, Managing Partner of Coastal Wealth, a member of the MassMutual Financial Group.
For further information contact Larry Hotz, [email protected] and 561-295-8254 x304.
WDSrx President Adam Runsdorf informed 150 guests at the Kravis Center about the unique role the company plays within the pharmaceutical supply chain.